肺腺癌;微小RNA;侵袭转移;基因治疗," /> 肺腺癌;微小RNA;侵袭转移;基因治疗,"/> Lung adenocarcinomaMicroRNAsInvasion and metastasisGene therapy ,"/>   <p class="MsoNormal"> <span>Effects of miR</span><span style="font-family:宋体;">-</span><span>1253 on proliferation</span><span style="font-family:宋体;">,</span><span>migration and invasion of lung adenocarcinoma cells</span>

Chinese Clinical Oncology ›› 2018, Vol. 23 ›› Issue (10): 865-869.

    Next Articles

 

Effects of miR-1253 on proliferationmigration and invasion of lung adenocarcinoma cells

 

    

  1. Department of Radiation Oncology Tangshan Peoples Hospital
  • Received:2017-11-20 Revised:2018-06-30 Online:2018-10-31 Published:2019-03-20
  • Contact: SUN Guogui E-mail:E-mail:guogui_sun2013@163.com

Abstract:  

Objective  To investigate the expression of microRNA-1253miR-1253 in lung adenocarcinoma cell lines and its effect on the proliferation migration and invasion of lung adenocarcinoma cells. Methods  Real-time fluorescence quantitative PCR QPCR was used to detect the expression of miR-1253 in lung adenocarcinoma cell lines A549 NCI-H1299 NCI-H157 A973 and GLC-82. miR-1253 mimics and miR-1253 inhibitor were transfected into A973 and NCI-H157 cells respectively. The cells transfected with negative control plasmid NC were used as negative controlNC group. The effects of different expression of miR-1253 on proliferation clone formation invasion and migration of A973 and NCI-H157 cells were examined by cell proliferation assay, clone formation assay and Transwell migration and invasion assay. Results  The results of QPCR showed that the relative expression of miR-1253 in A549 NCI-H1299 NCI-H157 A973 and GLC-82 cells were 0.92±0.06, 0.06±0.03, 1.10±0.26, 0.03±0.01 and 0.45±0.08 respectively. After transfection of miR-1253 mimics into A973 cells the relative expression of miR-1253 increased significantlyP0.05), and decreased significantly after transfection of miR-1253 inhibitor into NCI-H157 cells P0.05. Compared with the NC group the transfection of miR-1253 mimics could significantly inhibit the proliferation activity the ability of plate cloning166.0±29.3 vs. 371.0±31.4 P=0.001 and the ability of migration91.1±32.1 vs. 166.7±33.9 P=0.008 and invasion74.4±20.5 vs. 145.6±28.8P=0.001 of lung adenocarcinoma cell line A973 miR-1253 inhibitor can up-regulate the proliferation number of plate cloning cells545.0±61.9 vs. 337.0±39.7 P=0.008), migration246.7±36.7 vs. 151.1±32.9P0.001 and invasion231.1±38.8 vs. 137.8±27.3 P=0.001 of NCI-H157. Conclusion  miR-1253 could reduce malignant phenotype of lung adenocarcinoma cells and therefore it can be used as an effective target for gene therapy of lung adenocarcinoma.

Key words:  , Lung adenocarcinoma

Lung adenocarcinomaMicroRNAs">;MicroRNAsInvasion and metastasis">;Invasion and metastasisGene therapy ')">">;Gene therapy

CLC Number: 

  • R734.2
[1] YE Lu, MU Dan, YANG Li, FU Bo, WANG Min..

Targeted inhibition of Rab27a by microRNA-582-5p on biological behavior of lung cancer cells [J]. Chinese Clinical Oncology, 2019, 24(2): 102-107.

[2] YANG Sanhu, WEN Miaomiao, ZHANG Zhipei, LI Weimiao, YANG Feng, LI Xiaofei..

Relationship of ROS1 fusion gene mutation with EGFR mutation and clinicopathological features in non-small cell lung cancer [J]. Chinese Clinical Oncology, 2019, 24(2): 175-178.

[3] GE Qin, QIAN Xia, XIE Guodong, CAI Jing, YANG Baixia, WU Jianting, ZHAO Jizhong, CUI Juanjuan, ZHU Xinghua, CHU Chunxia. . The effect of EGFR and TGF-α in radiosensitization of lung cancer cells [J]. Chinese Clinical Oncology, 2019, 24(2): 145-148.
[4] GAO Xiaohui, ZHANG Yali, ZHANG Zhiye, GUO Yanzhen, CHEN Xiaobing..

Experimental study on the effect of miR-21 targeting Atg5 on the proliferation, migration and invasion of non-small cell lung cancer A549 cells by regulating autophagy [J]. Chinese Clinical Oncology, 2019, 24(2): 97-101.

[5] ZHANG Ning, LU Chuangxin, WU Sen, HE Yi, WEI Li. .

Expression and clinical significance of miRNA-138-5p in non-small cell lung cancer [J]. Chinese Clinical Oncology, 2019, 24(2): 149-152.

[6] QIN Boyu, SONG Qi, SUN Shengjie, SUN Qiong, TAO Ran, JIAO Shunchang. .

Progression of exosomes in non-small cell lung cancer drug resistance [J]. Chinese Clinical Oncology, 2019, 24(2): 179-182.

[7] WEI Danfeng, GUO Yuanbiao, WANG Zhanhao, ZHU Yifang..  The relationship between EGFR mutaion subtypes and the clinicopathological features of non-small cell lung cancer in Sichuan region [J]. Chinese Clinical Oncology, 2018, 23(10): 915-919.
[8] . [J]. Chinese Clinical Oncology, 2018, 23(10): 957-958.
[9] WANG Haitao, YANG Jingxian, SHUAI Shengsheng.. Effect of different working experience of radiation therapist on intensity modulated radiation therapy in elderly patients with stage Ⅲ non-small cell lung cancer [J]. Chinese Clinical Oncology, 2018, 23(5): 449-452.
[10] . [J]. Chinese Clinical Oncology, 2018, 23(5): 476-478.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!